CureVac N.V. (LON:0A9E)
London
· Delayed Price · Currency is GBP · Price in USD 3.111
+0.011 (0.36%)
At close: Apr 17, 2025
CureVac Market Cap
CureVac has a market cap or net worth of 537.36 million as of April 24, 2025. Its market cap has decreased by -1.01% in one year.
Market Cap
537.36M
Enterprise Value
192.23M
Revenue
442.58M
Ranking
n/a
PE Ratio
4.01
Stock Price
3.11
Market Cap Chart
Since August 14, 2020, CureVac's market cap has decreased from 7.51B to 537.36M, a decrease of -92.84%. That is a compound annual growth rate of -43.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 536.90M | -12.13% |
| Dec 31, 2024 | 610.99M | -17.45% |
| Dec 29, 2023 | 740.11M | -22.27% |
| Dec 30, 2022 | 952.09M | -79.91% |
| Dec 31, 2021 | 4.74B | -54.77% |
| Dec 31, 2020 | 10.48B | 39.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 157.23B |
| Shell | 146.99B |
| HSBC Holdings | 140.74B |
| Unilever | 120.20B |
| Rio Tinto Group | 75.78B |
| RELX PLC | 72.45B |
| British American Tobacco p.l.c. | 70.11B |
| London Stock Exchange Group | 61.21B |